Merck releases Gross/Net Pricing from 2010-2016, Amgen should do the same!!!

[anonymous]

Merck's Data: http://www.msdresponsibility.com/wp...-on-Pricing-Practices-in-the-US-2010-2016.pdf

AMGEN SHOULD DO THE SAME BUT FOR EACH DRUG!

 

[anonymous]

Enbrel had 9% increases every 6 months or 18% a year. Amgen was close to a 10% net price a year so it was worse.

 

[anonymous]

This chart shows a ~5% net price increase year over year. That's a 40% increase over a 7 year period.

If the drug was originally:

$10k -> $14k
$50k -> $70k

The cumulative nature of these drugs is expensive. Enbrel is a 20 year old drug, at a 5% increase, the lifetime net price increase is ~164%.

If the drug was $10k it's now $26.4k. A $50k is now $82k. With increases OOP Maxes and co-insurance rising, patients are indeed paying a lot more.

Say what you want about price increases not reflecting rebates but even at a modest 5% a year, these increases have a substantial effect over the life of a drug.